Gavi CEO meets PM, discusses strategic partnership in vaccine

Published On 2016-01-08 06:33 GMT   |   Update On 2016-01-08 06:33 GMT
Advertisement
NEW DELHI: Gavi, a global vaccine alliance, proposes to have a new strategic partnership with India for 2016-2021, which will see further fund support of up to $500 million to accelerate the introduction of modern vaccines for all children in the country.

The issue was discussed when Chief Executive Officer of Gavi Seth Berkley met Prime Minister Narendra Modi here.

They discussed innovation in vaccines and implementation of childhood immunisation in India.
Advertisement

Berkley was appreciative of the new innovative government initiatives, such as 'Mission Indradhanush' and 'Make in India', both of which are improving childhood immunisation in India, a PMO statement said.

Mission Indradhanush reaches the unvaccinated children.

During the meeting, Gavi's proposed new strategic partnership with India for 2016-2021 was discussed, which includes India's forthcoming rollout of vaccines that will protect children against causes of the biggest childhood killers, pneumonia and diarrhoea, as well as others such as measles-rubella and cervical cancer vaccines, it said.

They also discussed affordability, quality assurance and sustainability as well as using environmentally-sustainable technologies such as solar to improve the vaccine cold chain, not just in India but in all developing countries.

Gavi, the Vaccine Alliance, is a public-private global health partnership committed to increasing access to immunisation in poor countries.

It brings together developing countries and donor governments, the WHO, UNICEF, the World Bank, the vaccine industry in both industrialised and developing countries, research and technical agencies, civil society, the Bill & Melinda Gates Foundation and other private philanthropists.
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News